[go: up one dir, main page]

NO20005547D0 - Myelinbasiske proteinpeptider og anvendelser derav - Google Patents

Myelinbasiske proteinpeptider og anvendelser derav

Info

Publication number
NO20005547D0
NO20005547D0 NO20005547A NO20005547A NO20005547D0 NO 20005547 D0 NO20005547 D0 NO 20005547D0 NO 20005547 A NO20005547 A NO 20005547A NO 20005547 A NO20005547 A NO 20005547A NO 20005547 D0 NO20005547 D0 NO 20005547D0
Authority
NO
Norway
Prior art keywords
myelin
based protein
protein peptides
peptides
protein
Prior art date
Application number
NO20005547A
Other languages
English (en)
Other versions
NO20005547L (no
Inventor
Subhashini Arimilli
Shrikant Deshpande
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of NO20005547D0 publication Critical patent/NO20005547D0/no
Publication of NO20005547L publication Critical patent/NO20005547L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20005547A 1998-05-05 2000-11-03 Myelinbasisproteinpeptider og anvendelser derav NO20005547L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7310998A 1998-05-05 1998-05-05
PCT/US1999/009930 WO1999057241A2 (en) 1998-05-05 1999-05-05 Myelin basic protein peptides and uses thereof

Publications (2)

Publication Number Publication Date
NO20005547D0 true NO20005547D0 (no) 2000-11-03
NO20005547L NO20005547L (no) 2001-01-02

Family

ID=22111789

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005547A NO20005547L (no) 1998-05-05 2000-11-03 Myelinbasisproteinpeptider og anvendelser derav

Country Status (10)

Country Link
EP (1) EP1080185A4 (no)
JP (1) JP2002513558A (no)
CN (1) CN1308671A (no)
AU (1) AU3789099A (no)
CA (1) CA2330826A1 (no)
HK (1) HK1039636A1 (no)
NO (1) NO20005547L (no)
NZ (1) NZ507901A (no)
WO (1) WO1999057241A2 (no)
ZA (1) ZA200006268B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265208B2 (en) 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
JP4538192B2 (ja) * 2001-05-01 2010-09-08 ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア 免疫疾患を治療するための融合分子及び方法
ITFI20010114A1 (it) 2001-06-22 2002-12-22 Univ Firenze Glicopeptidi,loro preparazione e loro uso nella diagnosi o nel trattamento terapeutico della sclerosi multipla
DK2227486T3 (da) * 2007-11-20 2017-06-19 Vianex S A Peptidanaloger og konjugater dermed
EP3279218A4 (en) * 2015-03-30 2018-12-05 Osaka University Immunizing peptide, method for producing immunizing peptide, pharmaceutical composition for immune disorders containing same, and method for treating immune disorders
US20220313780A1 (en) * 2019-06-18 2022-10-06 The Scripps Research Institute Methods and compositions for treating inflammatory conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734023A (en) * 1991-11-19 1998-03-31 Anergen Inc. MHC class II β chain/peptide complexes useful in ameliorating deleterious immune responses
HUT77047A (hu) * 1994-10-25 1998-03-02 Immulogic Pharmaceutical Corporation Szklerózis multiplex kezelésére szolgáló készítmények és kezelések
KR19990022641A (ko) * 1995-06-07 1999-03-25 길버트 알. 민쯔 융합된 가용성 ｍｈｃ 헤테로이합체:펩티드 복합체 및 그것의 이용

Also Published As

Publication number Publication date
EP1080185A4 (en) 2005-01-26
NO20005547L (no) 2001-01-02
AU3789099A (en) 1999-11-23
WO1999057241A2 (en) 1999-11-11
NZ507901A (en) 2003-06-30
CA2330826A1 (en) 1999-11-11
WO1999057241A9 (en) 2000-02-17
ZA200006268B (en) 2001-08-22
CN1308671A (zh) 2001-08-15
HK1039636A1 (zh) 2002-05-03
WO1999057241A3 (en) 2000-01-13
JP2002513558A (ja) 2002-05-14
EP1080185A2 (en) 2001-03-07

Similar Documents

Publication Publication Date Title
IS4496A (is) Úðablöndur úr peptíðum og próteinum
NO20000700L (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO982097L (no) Peptider
NO982098D0 (no) Peptider
EP1461605A4 (en) NANOSTERIALS OF PROTEINS AND PEPTIDES
NO983364L (no) Konsensusproteiner
DK0954588T3 (da) OB fusionsprotein-sammensætninger og fremgangsmåder
NO985680L (no) Peptidderivater
EP1056465A4 (en) ANTIMICROBIAL PEPTIDES AND DERIVATIVE METAPEPTIDES
NO983849L (no) Peptidderivater
NO971448D0 (no) Anti-Fas rekombinante antistoffer og DNA derfor
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
GB9918155D0 (en) Proteins and peptides
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
DE69816241D1 (de) Aktivierte peptide und konjugate
ATE295417T1 (de) Angiostatin-bindendes protein
TR199701666A3 (tr) Sismanliga karsi proteinler
KR960010685A (ko) 펩티드 및 그 용도
NO20012283D0 (no) Koblede peptider
NO20006091D0 (no) Humant protein C-polypeptid
EP1127066A4 (en) MODIFIED PROTEINS
SE9802441D0 (sv) New peptides and use thereof
SE9802562D0 (sv) New peptides and use thereof
SE9701041D0 (sv) Novel proteins and their use
IS8568A (is) Vatnsfælanlega umbreyttar prótínsamsetningar og aðferðir

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application